Preparation of chitosan biguanidine/PANI-containing self-healing semi-conductive waterborne scaffolds for bone tissue engineering.
Shaabani A., Sedghi R.
Laboratory Study, published in Carbohydr Polym (2021) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Carbohydr Polym (2021)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 33910747
- DOI
- 10.1016/j.carbpol.2021.118045
Abstract (original English)
Electrically conducting self-healing scaffolds are known as a new series of intelligent biomaterial for regulating Human Adipose Mesenchymal Stem Cells biological behaviors, especially their differentiation to bone cells. Herein, we developed a novel hydrophilic semi-conductive chitosan derivative (CP) and loaded it into the self-healing waterborne polyurethane structure, as a new osteogenic agent. The fabricated scaffolds exhibited excellent shape memory properties with shape fixity (> 97 %) and shape recovery ratio (> 98 %) with excellent self-healing value (> 93 %) at a temperature close to the body temperature. The results of MTT, cell attachment, alkaline phosphatase activity, and alizarin red staining analysis demonstrated that the CP-contained scaffolds promote proliferation of hADSCs and matrix mineralization. Also, by introducing the CP the gene expression level of COL-1, ALP, RUNX2, and OCN were significantly enhanced, in line with matrix mineralization. These multifunctional engineered constructs are promising biomaterials for repairing various bone defects.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.